PepGen Inc.(PEPG)

Biotechnology · Boston, MA

$2.31-0.05 (-2.12%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T21:57:50.732Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:57:50.732Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 2.31
Unrounded diluted TTM EPS · period ending 2026-06-30: -1.5

FMP input reference: 4553d85706fed5bac33927ddb0c45062b9ca990621471d16f8faa1ad8920ffc8

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

PEPG PE Ratio Metrics

PE RATIO

N/A

PEPG Competitors' PE Ratio

PEPG

PepGen Inc.

Current

Market Cap

$159.78M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NERV

Minerva Neurosciences, Inc.

vs PEPG

Market Cap

$159.80M

PE Ratio

N/A

TTM Avg

4.03

3Y Avg

4.03

5Y Avg

14.59

LFMDP

LifeMD, Inc.

vs PEPG

Market Cap

$159.22M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CHRS

Coherus Oncology, Inc.

vs PEPG

Market Cap

$159.14M

PE Ratio

N/A

TTM Avg

5.36

3Y Avg

5.36

5Y Avg

8.25

QTRX

Quanterix Corporation

vs PEPG

Market Cap

$162.04M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INGN

Inogen, Inc.

vs PEPG

Market Cap

$156.22M

PE Ratio

N/A

TTM Avg

65.68

3Y Avg

52.50

5Y Avg

80.75

NKTX

Nkarta, Inc.

vs PEPG

Market Cap

$165.27M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OPRX

OptimizeRx Corp.

vs PEPG

Market Cap

$165.32M

PE Ratio

37.71

TTM Avg

23.37

3Y Avg

23.37

5Y Avg

443.72

STIM

Neuronetics, Inc.

vs PEPG

Market Cap

$153.79M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MENS

Jyong Biotech Ltd. Ordinary Shares

vs PEPG

Market Cap

$153.58M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
PepGen Inc. (PEPG)	$159.78M	N/A	N/A	N/A	N/A
Minerva Neurosciences, Inc. (NERV)vs ›	$159.80M	N/A	4.03	4.03	14.59
LifeMD, Inc. (LFMDP)vs ›	$159.22M	N/A	N/A	N/A	N/A
Coherus Oncology, Inc. (CHRS)vs ›	$159.14M	N/A	5.36	5.36	8.25
Quanterix Corporation (QTRX)vs ›	$162.04M	N/A	N/A	N/A	N/A
Inogen, Inc. (INGN)vs ›	$156.22M	N/A	65.68	52.50	80.75
Nkarta, Inc. (NKTX)vs ›	$165.27M	N/A	N/A	N/A	N/A
OptimizeRx Corp. (OPRX)vs ›	$165.32M	37.71	23.37	23.37	443.72
Neuronetics, Inc. (STIM)vs ›	$153.79M	N/A	N/A	N/A	N/A
Jyong Biotech Ltd. Ordinary Shares (MENS)vs ›	$153.58M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$2.31

Forward EPS (Est.)

$-1.06

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

PEPG PE Ratio Metrics

PEPG Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics